-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On September 8, Sialon Pharmaceutical issued an announcement stating that its wholly-owned subsidiary, Hunan Sialon Pharmaceutical, had recently obtained the "Approval Notice for Supplementary Drug Application" for injection of pantoprazole sodium approved and issued by the National Medical Products Administration
Pantoprazole for injection is mainly suitable for duodenal ulcer; gastric ulcer; moderate and severe reflux esophagitis; duodenal ulcer, gastric ulcer, acute gastric mucosal lesions, compound gastric ulcers, etc.